Clinical Trial Update: Pilot-Study of Thalidomide in Amyotrophic Lateral Sclerosis (ALS) [Phase 2]

View source ↗

Summary

A Phase 2 pilot study evaluating thalidomide in amyotrophic lateral sclerosis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Thalidomide (thalidomide)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Amyotrophic Lateral Sclerosis (ALS) | Phase 2 | Status: TERMINATED